3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
9
Phase 1
6
Phase 1/2
2
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Myelodysplastic Syndromes
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Recurrence
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Interventions
Radiosurgery
27
Blood Specimen Collection
20
Drug Therapy
18
Radiotherapy
14
Early Intervention, Educational
14
Magnetic Resonance Spectroscopy
13
Standard of Care
12
Pemetrexed
12
Carboplatin
12
Exercise
11
Practice Guidelines as Topic
9
X-Rays
8
Psychiatric Rehabilitation
8
Methods
8
Immunotherapy
8
Therapeutics
7
Surgical Procedures, Operative
7
Paclitaxel
7
Fluorodeoxyglucose F18
7
Surveys and Questionnaires
6
Counseling
6
Cisplatin
6
Biopsy
6
Anterior Temporal Lobectomy
6
Thoracic Surgery, Video-Assisted
5
Liquid Biopsy
5
Gemcitabine
5
Erlotinib Hydrochloride
5
Docetaxel
5
Bevacizumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Carcinoma, Non-Small-Cell Lung
×
sargramostim
×
Clear all
NCT03489616
2018-04-05
CRAGMOLC
Shandong Cancer Hospital and Institute
Phase NA
Unknown
45 enrolled